Oliver Meier possesses extensive experience in quality assurance and compliance within the pharmaceutical industry. Currently serving as Global QA Head for Nitrosamines and Mutagenic Impurities at Sandoz since May 2023, Oliver leads corporate governance and risk assessment activities throughout the product life-cycle. Prior roles at Novartis from 2005 to 2023 include positions such as QA Head for Compliance Operations, Global Head of ESO QA Transformation, and Global Head of GxP Training. Oliver's career also includes significant roles at Novartis Ophthalmics AG, ROCHE AG, CONFARMA Sarl, and Solvay Pharmaceuticals GmbH, focusing on microbiology and quality management systems. Oliver holds a graduate engineering degree in Hygiene/Microbiology from the University of Applied Science at Albstadt-Sigmaringen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices